ESR1 and breast cancer: In keeping with data obtained from patient-derived samples of different BC subtypes and the finding that tumor cells are the main source of PTX3, analysis in the GOBO database revealed that the majority of TNBC cell lines express higher levels of PTX3 mRNA in respect to the HER+ and ER+/PR+ counterpart (Fig. 1F).